in this issue
Regions :: North America :: U.S.
FDA and European Medicines Agency strengthen collaboration in pharmacovigilance
5:12 AM MST | February 20, 2014 | Deepti Ramesh
The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA; London) have set-up a new 'cluster' on pharmacovigilance or medicine safety. Clusters are regular collaborative meetings between the EMA and regulators outside of the European Union (EU), which focus on specific topic areas that have been identified as requiring an intensified exchange of information and collaboration. Building on the recent creation of the EMA’s pharmacovigilance risk assessment committee, this cluster will provide a forum for a more systematic and focused...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee